BNGO

What BNGO does

BNGO - Berufsverband Niedergelassener und ambulant tätiger Gynäkologischer Onkologen in Deutschland e.V. is a German non-profit professional association (eingetragener Verein, registered association) founded in November 2002 in Berlin. It represents approximately 124 highly specialized office-based and outpatient gynecological oncologists practicing across 96 practices in all 16 German federal states (Bundesländer). The association's core mission is to promote quality-assured, ambulatory, community-based care for women with breast cancer and other gynecological tumors, in line with the statutory principle of "ambulatory as much as possible, inpatient as necessary."

The association's product surface is membership-driven and centered on five pillars: (1) socio-political advocacy, including participation in DMP-Programm Mammakarzinom and membership in Spitzenverband Fachärzte Deutschlands e.V. (SpiFa) since 2015; (2) quality assurance via a mandatory documentation system and multi-round patient satisfaction surveys (running since 2012, with a 5th edition launched in 2019); (3) certified continuing medical education (CME), including the AGO certification curriculum delivered in cooperation with MedConcept GmbH; (4) scientific study participation through partnerships with AGO, DGHO, and NOGGO, generating real-world breast cancer treatment data presented at SABCS, ASORS, DGHO, MASCC, Senologiekongress, and DKK; and (5) member communications via the Journal Onkologie (official publication organ since 2014) and the annual BNGO-Hauptstadtkongress. A Cooperation Advisory Board of approximately 17 pharmaceutical and medical device companies (including Amgen, AstraZeneca, Daiichi-Sankyo, Gilead, GSK, Lilly, MSD, Pfizer, and Roche) operates under §10 of the statutes to coordinate industry engagement.

Revenue is generated entirely through annual membership dues (EUR 400 per member standard, EUR 300 per member for joint-practice groups) and undisclosed industry sponsorship via the Cooperation Advisory Board and CME events. The organization is governed by a volunteer board led by Chairman Dr. Jörg Schilling and Deputy Chair Dr. med. Steffi Busch, supported by a small secretariat in Neuenhagen bei Berlin. There is no parent company, no outside investors, and no disclosed financial statements; BNGO operates as an independent member-funded association.

Name

BNGO

Legal name

Berufsverband Niedergelassener und ambulant tätiger Gynäkologischer Onkologen in Deutschland e.V.

Website

https://bngo.de

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

51–100 employees

Short description

BNGO is a German non-profit professional association representing approximately 124 office-based and outpatient gynecological oncologists across 96 practices in all 16 federal states, providing political advocacy, CME-accredited training, quality assurance, and scientific research collaboration for ambulatory gynecological oncology.

Ownership category

akta.pro rank

Headquarters

HQ city

Neuenhagen

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Membership Dues: BNGO generates revenue through annual membership fees. The standard annual membership fee is EUR 400 per member. For members within a joint practice (Gemeinschaftspraxis) with multiple BNGO members, the fee is reduced to EUR 300 per member per year.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

BNGO is a German professional medical association (eingetragener Verein) that represents approximately 124 office-based and outpatient gynecological oncologists across 96 practices in all 16 German federal states. The association delivers membership-based services including quality assurance programs, CME-accredited continuing education, political and professional advocacy, scientific study participation, and publication of the official Journal Onkologie.

Product overview

BNGO is a professional medical association (Berufsverband) representing approximately 124 practicing and office-based gynecological oncologists across 96 practices in Germany. The organization does not offer traditional software products but provides professional services including membership representation, the Journal Onkologie as its official publication, CME-accredited continuing education modules, professional conferences and events, patient survey research programs, and scientific publications. The core offering is professional membership services that support quality assurance, training, and advocacy for ambulatory gynecological oncology care.

Differentiator

Problem solved

Functional benefit

Products and services

• BNGO Professional Membership Services Professional membership organization for practicing gynecological oncologists in Germany, offering representation, networking, quality assurance, and continuing education support.
• Journal Onkologie The official journal of BNGO, published as a professional medical publication covering gynecological oncology topics, research findings, and clinical updates.
• BNGO Continuing Education (Fortbildungen)

Quantifiable outcome

• Patient satisfaction surveys conducted since 2012, with multi-year trend data showing sustained high satisfaction scores in BNGO member practices

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Ten partnerships are on record, tiered core and minor.

• Spitzenverband Fachärzte Deutschlands e.V. (SpiFa)coreStrategic or Co-development Partner · 27 February 2015BNGO has been a member of SpiFa since 2015. SpiFa is the leading umbrella organization representing the interests of office-based specialist physicians in Germany. Through this membership, BNGO advocates for the interests of gynecological oncologists at the national political level, including in debates over the GOÄ (Gebührenordnung für Ärzte) and other health policy issues.
• DGHO (Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie)coreStrategic or Co-development PartnerBNGO cooperates with DGHO regarding the conduct of scientific studies and continuing education events. DGHO is one of Germany's most prominent professional oncology societies. BNGO also participated in joint policy statements with DGHO, including on COVID-19 vaccination recommendations for cancer patients and a joint position paper on methadone use in oncology.
• NOGGO e.V. (Nordostdeutsche Gesellschaft für Gynäkologische Onkologie)coreStrategic or Co-development PartnerBNGO cooperates with NOGGO regarding the conduct of scientific studies and continuing education events. NOGGO is a regional but significant gynecological oncology society based in Berlin. BNGO promotes NOGGO events such as 'Update Gynäkologische Onkologie' on its website.
• AGO (Arbeitsgemeinschaft Gynäkologische Onkologie)coreStrategic or Co-development PartnerBNGO cooperates with AGO regarding the conduct of scientific studies and continuing education events. AGO is Germany's leading professional group for gynecological oncology within the German Cancer Society. BNGO supports and promotes AGO certification courses through MedConcept GmbH.
• MedConcept GmbHcoreGTM or Marketing PartnerMedConcept GmbH organizes and manages BNGO's continuing education events including the Curriculum Onkologie, Refresher courses, and AGO certification courses. BNGO promotes these events on its website slider and events page. The partnership enables delivery of CME-accredited training to BNGO members and the broader gynecological oncology community.
• BNGO Kooperationsbeirat (Cooperation Advisory Board) – Multiple CompaniesminorGTM or Marketing PartnerBNGO maintains a transparent cooperation advisory board with pharmaceutical and medical device companies including Amgen GmbH, APOGEPHA Arzneimittel GmbH, AstraZeneca GmbH, BIODERMA, Celltrion Healthcare Deutschland GmbH, Daiichi-Sankyo Deutschland GmbH, Eisai GmbH, ESTEVE Pharmaceuticals GmbH, Gilead Sciences GmbH, GlaxoSmithKline GmbH & Co. KG, L'Oreal GmbH La Roche-Posay, Lilly Deutschland GmbH, MSD Sharp & Dohme GmbH, Pfizer Pharma GmbH, Pharmanovia GmbH, Roche Pharma AG, and Stemline Therapeutics Inc./Menarini. The board operates under §10 of BNGO's statutes.
• Global Academy of Women's Cancer (GAWC)minorStrategic or Co-development PartnerBNGO is a Partner Society of the Global Academy of Women's Cancer, an internationally renowned scientific event bringing together leading experts in gynecological oncology. BNGO supports GAWC 2026 in Istanbul (January 30–31, 2026) as a Partner Society, contributing to international scientific exchange and the advancement of gynecological oncology care.
• Deutsche Krebsgesellschaft e.V.minorOthersListed as a partner on BNGO's Links page. The German Cancer Society provides comprehensive information about cancer and is a key reference organization in German oncology.
• Deutsche Gesellschaft für SenologieminorOthersListed as a partner on BNGO's Links page. The German Society for Senology focuses on breast diseases diagnostics and therapy, highly relevant to BNGO's focus on breast cancer.
• Deutsche KrebshilfeminorOthersListed as a partner on BNGO's Links page. The German Cancer Aid is one of Germany's largest and most influential cancer charities, providing information and support for cancer patients.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Deutsche Krebsgesellschaft (DKG): German Cancer Society, the umbrella oncology organization under which AGO operates; comparable as a membership-driven oncology organization providing certification, guidelines, and policy advocacy at a national scale well beyond BNGO's ambulatory niche.
• Hartmannbund: Germany's professional association for physicians across all specialties; comparable as a membership-based physician association providing political advocacy and member services, though broader in mandate than BNGO.
• Berufsverband Deutscher Internistinnen und Internisten (BDI): Germany's largest internal-medicine professional association; comparable as a physician membership organization providing policy advocacy and CME, though operating in a different (internal medicine) specialty.
• Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie (DGHO): Germany's leading scientific oncology society and a BNGO cooperation partner; comparable as a membership-driven oncology organization offering CME, scientific exchange, and policy advocacy, though focused on the broader hematology/oncology community.
• Berufsverband der Frauenärzte (BVF): Germany's professional association for gynecologists; comparable as a physician specialty association providing political representation and CME, though broader in scope (full OB/GYN rather than gynecological oncology).
• Spitzenverband Fachärzte Deutschlands e.V. (SpiFa): Umbrella association for office-based specialist physicians in Germany and BNGO's parent federation since 2015; comparable as a physician professional association providing political advocacy, though operating across all specialties rather than gynecological oncology specifically.

Regional players

• European Society of Gynaecological Oncology (ESGO): European-level gynecological oncology society; comparable in clinical focus and CME/scientific mandate, though operating internationally rather than at the German national level BNGO serves.

Direct peers

• Arbeitsgemeinschaft Gynäkologische Onkologie (AGO): Leading professional group for gynecological oncology within the German Cancer Society and BNGO's core scientific partner; directly comparable as a gynecological-oncology membership organization running certification courses, guidelines, and study programs.
• Nordostdeutsche Gesellschaft für Gynäkologische Onkologie (NOGGO): Regional but significant gynecological oncology society based in Berlin; closely comparable to BNGO as a gynecological-oncology association running CME events and scientific studies in overlapping membership geographies.

Peers

• Deutsche Gesellschaft für Senologie (DGS): German Society for Senology focused on breast disease diagnostics and therapy; comparable as a BNGO partner society addressing overlapping breast-cancer clinical and policy territory, including the 2012 award that recognized BNGO's patient satisfaction research.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInde.linkedin.com/company/bngo-e-v
• Instagraminstagram.com/bngo_ev

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BNGO